BridgeBio Pharma, Inc.
NASDAQ:BBIO
Overview | Financials
Company Name | BridgeBio Pharma, Inc. |
Symbol | BBIO |
Currency | USD |
Price | 25.2 |
Market Cap | 4,738,431,600 |
Dividend Yield | 0% |
52-week-range | 21.62 - 44.32 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Neil Kumar Ph.D. |
Website | https://www.bridgebio.com |
An error occurred while fetching data.
About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD